Willekens, Jeremy
Ramjan, Sameera
Sands, Stephen A.
Park, Yongkyu
K.C., Nirajan
Burns, Melissa A.
Welch, Jennifer J. G.
Kahn, Justine
Kelly, Kara M.
Tran, Thai-Hoa
Michon, Bruno
Gennarini, Lisa
Place, Andrew
Silverman, Lewis B.
Cole, Peter D.
Funding for this research was provided by:
National Cancer Institute (R01 CA220568)
New Jersey Pediatric Hematology and Oncology Research Center of Excellence
Article History
Received: 25 October 2025
Accepted: 17 December 2025
First Online: 30 December 2025
Declarations
:
: Institutional review board approval was obtained at each site for the treatment protocol and ancillary studies. Informed consent was provided by the participants’ guardians or by patients over the age of 18. Written assent was also obtained from the pediatric patients on the basis of institutional guidelines. All procedures were conducted in accordance with relevant ethical regulations and the approvals of the participating institutional review boards.
: Not applicable. This study does not include any identifiable individual person’s data, images, or videos. All data analyzed were de-identified and obtained under institutional review board-approved protocols with informed consent for research participation and sample collection.
: The authors declare no competing interests.